Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06278961 · ClinicalTrials.gov registry record
Families Filming Infants Learning Movement
A clinical trial of Cerebral Palsy and Infant Development, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Recruiting
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT06278961: Recruiting study of Cerebral Palsy and Infant Development, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT06278961 is a study of Cerebral Palsy and Infant Development that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 350 participants, above the 226-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (55% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06278961, a study of Cerebral Palsy and Infant Development, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without medical complexity. The study team plans to recruit 100 healthy, term-born infants and 250 infants at risk of developing CP for a total of 350 enrolled infants.
Primary Outcome
Identify the timeframe in which fidgety movements are consistently present in healthy, term born infants
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
Illinois
- Feinberg School of Physical Therapy and Human Movement Sciences - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2021-01-28 |
| Est. Completion | 2026-09-30 |
What NCT06278961 shows while recruiting
NCT06278961 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 226-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (55% higher).
The record links to 4 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT06278961 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06278961 about?
NCT06278961 is a clinical study titled "Families Filming Infants Learning Movement". The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without...
What is the current status of trial NCT06278961?
This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2021-01-28. Estimated completion is 2026-09-30.
What conditions does trial NCT06278961 study?
This clinical trial studies the following conditions: Cerebral Palsy, Infant Development, Neurological Disorder, Motor Disorders.
What interventions are being tested in trial NCT06278961?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT06278961?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06278961 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06278961's enrollment target sits among peer trials
350 7th of 91 higher than 85 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI